Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
ID: 342125Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/342125

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-193.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for a Data Coordinating Center (DCC) to support multi-site investigator-initiated clinical trials through a cooperative agreement. The DCC will be responsible for project coordination, data management, and biostatistical support, collaborating closely with a Clinical Coordinating Center (CCC) to enhance community engagement and diversity in clinical trial recruitment. This initiative is crucial for advancing research in therapeutic and preventive strategies, particularly in addressing health disparities through diverse clinical trial participation. Interested applicants must submit their proposals by September 11, 2025, and can find additional information and guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-193-Full-Announcement.html
    PAR-22-193.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is offering a funding opportunity for a Data Coordinating Center (DCC) for multi-site investigator-initiated clinical trials. This initiative aims to support clinical trials aimed at assessing the efficacy of therapeutic and preventive strategies, with specific encouragement for innovative trial designs. The DCC will collaborate with a Clinical Coordinating Center (CCC) and is required to manage project coordination, data management, and biostatistical support, demonstrating effective collaboration with the CCC to enhance community engagement and diversity in clinical trial recruitment. Key dates indicate the open application period from September 11, 2022, until September 12, 2025. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, governments, and foreign institutions. Applications must comply with NIH guidelines, including performance-driven milestones, participant safety, and the inclusion of underrepresented populations in clinical research. Successful applicants will demonstrate effective project management capabilities, innovative approaches to trial design, and compliance with funding policies. This funding opportunity emphasizes NIH's commitment to diversity within the research workforce and the necessity for diverse clinical trial participation to address health disparities.
    Similar Opportunities
    Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the development of a Clinical Coordinating Center (CCC) to support multi-site investigator-initiated clinical trials under the UG3/UH3 activity codes. This initiative aims to foster innovative trial designs relevant to the National Heart, Lung, and Blood Institute's (NHLBI) research mission, requiring comprehensive project plans that address participant recruitment, milestone achievements, and strategies for enhancing community engagement and diversity. The funding mechanism is bi-phasic and necessitates simultaneous applications for both a CCC and a collaborating Data Coordinating Center (DCC), emphasizing strong project management and a commitment to minimizing health disparities. Interested applicants must submit their proposals by September 11, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. More details can be found in the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-192.html.
    Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of a Clinical Coordinating Center (CCC) to support multi-site investigator-initiated clinical trials focused on natural products, such as botanicals and dietary supplements. Applicants are required to submit a comprehensive plan detailing project management, participant recruitment, and clinical trial execution, while also ensuring alignment with NIH standards. This initiative emphasizes the importance of evidence-based research in natural products and mandates the submission of a corresponding Data Coordinating Center (DCC) proposal to oversee data management and analysis. Interested applicants should note that the application deadline is July 15, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For additional details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-24-123.html.
    Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for a phased multi-site clinical trial aimed at preventing cardiovascular disease (CVD) in young adults with high lifetime risk, specifically through the establishment of a Data Coordinating Center (DCC). The DCC will be responsible for overall project coordination, administration, data management, and biostatistical support for the trial, which will evaluate the efficacy of pharmacological interventions against a control group while focusing on health equity and community engagement. This initiative is critical for addressing the rising incidence of CVD among young adults by employing innovative trial designs and strategies to enhance diverse perspectives. Applications are due by October 28, 2024, with a total budget allocation starting at $972,356 for fiscal year 2025, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for a cooperative agreement to establish the Data Coordinating Center (DCC) for the Stillbirth Research Consortium, aimed at reducing stillbirth rates, particularly among marginalized populations. The DCC will be responsible for managing data collection, providing technical support, and enhancing coordination among various research projects focused on stillbirth prevention. This funding opportunity underscores the federal government's commitment to addressing perinatal mortality through innovative research strategies and interdisciplinary collaboration. Interested applicants should note that the application submission period begins on October 1, 2024, with approximately $2.25 million available for FY 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Coordinating Center for Type 1 Diabetes TrialNet (TNCC) through a cooperative agreement, aimed at supporting research initiatives focused on the prevention and intervention of type 1 diabetes (T1D). The TNCC will manage a variety of research projects, oversee data and sample management, and facilitate the selection of clinical centers necessary for conducting clinical studies related to T1D. This initiative underscores the federal commitment to advancing T1D research and treatment, with a total funding availability of approximately $29.5 million. Interested applicants must submit their proposals by October 17, 2024, and are required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a cooperative agreement for the establishment of the Chronic Pancreatitis Clinical Research Consortium Data Coordinating Center (CPCRC-DCC) under funding opportunity RFA-DK-25-020. The primary objective is to facilitate ongoing studies on chronic pancreatitis, diabetes, and pancreatic cancer, focusing on data management, biomarker development, and clinical trial support for both pediatric and adult populations. This initiative is crucial for advancing the understanding of chronic pancreatitis and its associations with diabetes and pancreatic cancer, with an anticipated funding amount of $6.5 million over five years. Interested applicants must submit their proposals by 5:00 PM on October 19, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the establishment of a Data Management and Coordinating Center (DMCC) as part of the Rare Diseases Clinical Research Network (RDCRN). This initiative aims to enhance the diagnosis, management, and treatment of rare diseases by facilitating collaborative, multi-site, patient-centric research through the RDCRN and supporting the activities of the Rare Diseases Clinical Research Consortia (RDCRC). The estimated total program funding for this grant is $1,000,000, with the FOA expected to be published in 2024 and awards anticipated in 2025. Interested applicants can reach out to Dr. Tiina K. Urv at urvtiin@mail.nih.gov or by phone at 301-827-2746 for further information.
    Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Cancer Prevention Clinical Trials Network (CP-CTNet) to establish a Data Management, Auditing, and Statistical Center (DMASC) through a cooperative agreement. This initiative aims to support the design and execution of early-phase clinical trials focused on cancer prevention strategies, assessing the safety, tolerability, and efficacy of various interventions while enhancing operational efficiencies and data integration across the network. The DMASC will play a crucial role in providing centralized data management, auditing clinical trial processes, and offering statistical support, ultimately addressing significant public health challenges related to cancer prevention. The project is set for a six-year period with an annual funding commitment of $3,250,000, and interested applicants must submit their proposals by October 31, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)" aimed at enhancing resources for investigating undiagnosed diseases through a network of clinical sites. This initiative seeks to designate successful applicants as Diagnostic Centers of Excellence (DCoE), which will be responsible for generating clinical data to be shared with the Data Management Coordinating Center (DMCC), thereby promoting collaboration among clinicians and researchers to improve diagnostic capabilities, particularly for health disparity populations. The program does not provide direct budgetary support but allows successful applicants to apply for subawards for research activities, with applications open from April 15, 2023, until the final deadline of May 15, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.